Overview
Updated 14 Jul 2026
Caron A. Jacobson, MD, is Medical Director, Immune Effector Cell Therapy Program at Dana-Farber Cancer Institute, Boston, MA. The public record shows 577 publications with 23,849 citations (h-index 61), centered on Lymphoma. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 18 companies.
- Most recent indexed publication: 2026 · Clinical cancer research
- Top research focus: Lymphoma
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 18 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 9 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Axi-cel in CNS Lymphoma
Sponsor: Dana-Farber Cancer Institute
InvestigatorPhase 1Active, not recruitingNCT04608487 - Rituximab + Immunotherapy in Follicular Lymphoma
Sponsor: Dana-Farber Cancer Institute
InvestigatorPhase 1TerminatedNCT03636503 - Phase 2 Study of AT13387 (Onalespib) in ALK+ ALCL, MCL, and BCL-6+ DLBCL
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2TerminatedNCT02572453
Industry payments
Updated 14 Jul 2026
18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year202521 payments$23,526openpaymentsdata.cms.gov ↗
- ADC THERAPEUTICS AMERICA, INC.Program year202510 payments$14,259openpaymentsdata.cms.gov ↗
- ABBVIE INC.Program year20254 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
450 Brookline Avenue, Boston, MA 02215
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- MD
Columbia University College of Physicians & Surgeons
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- Residency
Internal Medicine, Columbia University/New York-Presbyterian Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗ - Fellowship
Hematology/Oncology, Dana-Farber/Partners CancerCare
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Editorial & leadership rolesjournal and society appointments
- Principal Investigator
multiple CAR T-cell clinical trials in B-cell non-Hodgkin lymphoma, Dana-Farber Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Awards & honorshonors on the public record
- LLS (Blood Cancer United) Scholar in Clinical Research grant
for CAR T-cell therapy research in CNS lymphoma
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →bloodcancerunited.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →defycancer.dana-farber.org ↗
Secondary affiliationsappointments beyond the home institution
- Associate Professor of Medicine
Harvard Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - Member
Dana-Farber/Harvard Cancer Center (DF/HCC)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →dfhcc.harvard.edu ↗ - Physician
Brigham and Women's Hospital
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →physiciandirectory.brighamandwomens.org ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
- Guest
"How CAR T-cell Therapy Gives Hope to Cancer Patients," The Bloodline with Blood Cancer United (podcast)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →thebloodline.org ↗ - Featured speaker
"CAR-T Cell Therapy for Lymphoma: Updates and Progress" (Dana-Farber physician video)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physicianresources.dana-farber.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/caron-jacobson-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Other
thebloodline.org/096-e96
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →thebloodline.org ↗ - Other
onclive.com/authors/caron-a.-jacobson,-md,-dana-farber-cancer-institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Seth Steinberg, PhD
National Institutes of Health
- 1,645
- publications
- 150
- h-index
Anne Tsao, MD
The University of Texas MD Anderson Cancer Center
- 591
- publications
- 86
- h-index
- 13
- trials
David Maloney, MD, PhD
Fred Hutchinson Cancer Research Center
- 843
- publications
- 111
- h-index
- 14
- trials
Stephen Ansell, MD, PhD
Mayo Clinic
- 1,478
- publications
- 113
- h-index
- 10
- trials